BAY-985
- CAS NO.:2409479-29-2
- Empirical Formula: C27H30F3N9O
- Molecular Weight: 553.58
- MDL number: MFCD32690108
- Update Date: 2026-04-24 14:58:50
What is BAY-985?
Biological Activity
BAY-985 is a potent and highly selective TBK1/IKKε inhibitor. It is highly potent against TBK1 (IC50 = 2 nM, low ATP assay; 30 nM, high ATP assay) and IKKε (IC50 = 2 nM) and also in mechanocellular phosphorylation of interferon regulatory factor 3 (pIRF3) assays High potency (IC50 = 74 nM) and anti-proliferative effect on SK-MEL-2 cells (IC50 = 900 nM).
in vitro
BAY-985 inhibits FLT3, RSK4, DRAK1, and ULK1 with IC 50 s of 123, 276, 311, and 7930 nM, respectively.
BAY-985 inhibits the cellular phosphorylation of interferon regulatory factor 3 (IRF3) with an IC 50 of 74 nM.
BAY-985 is active in cellular mechanistic assay and shows anti-proliferative activity in a few cancer cells lines with IC 50 s of 900 and 7260 nM for SK-MEL2 (NRAS and TP53 mutated) and ACHN (CDKN2A mutated) cells, respectively.
Cell Proliferation Assay
| Cell Line: | ACHN and SK-MEL-2 cell lines |
| Concentration: | |
| Incubation Time: | td>96 hours |
| Result: | Inhibited proliferation i n SK-MEL2 and ACHN cells with IC 50 s of 900 and 7260 nM, respectively. |
in vivo
BAY-985 (200 mg/kg; po; bid; 111 days) results in weak antitumor efficacy.
BAY-985 shows high clearance (CL b = 4.0 L/h/kg, ca. 95% hepatic extraction), large volume of distribution at steady state (V ss =2.9 L/kg) and a short terminal half-life (t 1 /2 =0.79 h).
| Animal Model: | Female NMRI nude mice bearing SK-MEL-2 human melanoma xenograft model |
| Dosage: | 200 mg/kg |
| Administration: | Applied po; twice daily (bid) continuously 111 days |
| Result: | Treatment resulted in weak antitumor efficacy with a T/C tumor weight ratio of 0.6. The treatment was well tolerated, with a maximum body weight loss of less than 10%. |
Properties of BAY-985
| Boiling point: | 753.3±70.0 °C(Predicted) |
| Density | 1.373±0.06 g/cm3(Predicted) |
| storage temp. | Store at -20°C |
| solubility | DMSO: 50 mg/mL (90.32 mM) |
| pka | 10.06±0.10(Predicted) |
| form | A solid |
| color | Light yellow to yellow |
Safety information for BAY-985
Computed Descriptors for BAY-985
New Products
6-Hydroxy-2,4-Diaminopyrimidine 2,6-Dipicolic Acid 3-AMINO-3-(2-CHLORO-PHENYL)-PROPIONIC ACID 4-Fluorophenylglycine 1-N-Boc-3-(aminoethyl)azetidine Dimedone 1-Boc-3-(cyanomethyl)azetidine N-BOC-piperidine-4-carboxylic acid 3-Hydroxypyridine 2-Bromo-5-Chloro-3-Nitropyridine 2-Amino-3-Nitro-5-Chloro Pyridine 2-Amino-5-Iodopyridine 5-Amino-2-Hydroxypyridine 2,5-Dibromopyridine 2-BROMOACETYL BROMIDE-D2 METHANE SULFONIC ACID-D4 PHOSPORIC ACID-D3 85 W% IN D2O DEUTERIUM OXIDE FOR NMR BENZENE-D6 TOLUENE-D3 5-Acetylsalicylamide 1-(3-Chlorophenyl)-4-(3-Chloropropyl) piperazine hydrochloride 4-(Methyl amino)-3-Nitro benzoic acid 3,4,5-Trimethoxy benzoic acidRelated products of tetrahydrofuran


![Benzamide, N-[5-(3,5-dicyano-1,4-dihydro-1,2,6-trimethyl-4-pyridinyl)-6-fluoro-7-methyl-1H-indazol-3-yl]-2-ethyl-](https://img.chemicalbook.in/CAS/20210305/GIF/2377576-35-5.gif)




You may like
-
67914-85-6 cis-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolane-4-methanol (IT8)View Details
67914-85-6 -
350-03-8 3-AcetylpyridineView Details
350-03-8 -
6-Chloro-2,4-Diamino pyrimidine 156-83-2View Details
156-83-2 -
1-(4-Aminophenyl)-4-(4-methoxyphenyl)Piperazine 74852-62-3View Details
74852-62-3 -
556-08-1 4-Acetamidobenzoic acidView Details
556-08-1 -
61397-56-6View Details
61397-56-6 -
5-Bromo-2-Chlorobenzoic acid 21739-92-4View Details
21739-92-4 -
15128-52-6View Details
15128-52-6
